Patent Foramen Ovale (PFO) After Stroke: Meta-analysis suggests the application of a multivariable causal classification system may better distinguish patient subgroups who may benefit from PFO closure from those unlikely to receive benefit.
7 Feb, 2022 | 08:31h | UTCHeterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke – JAMA (link to abstract – $ for full-text)
Commentary: Classification System May Identify Patients Likely to Benefit from PFO Closure – Physician’s Weekly
Related:
Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases
Commentary on Twitter
Analysis of individual patient data from RCTs found application of a multivariable causal classification system to randomized trial results that distinguished subgroups who may benefit from patent foramen ovale (PFO) closure vs those unlikely to benefit https://t.co/L9Ic9EsNPG
— JAMA (@JAMA_current) December 15, 2021